A new generation of DNA-sequencing platforms will become commercially available over the next few years. These instruments will enable re-sequencing of human genomes at a previously unimagined throughput and low cost. Here, I examine why the $1,000 human genome is an important goal for research and clinical diagnostics, and what will be required to achieve it.
引用
收藏
页数:5
相关论文
共 16 条
[11]
Robertson JA., 2003, AM J BIOETHICS, V3, pW, DOI DOI 10.1162/152651603322874762